Drugs / Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine
Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01000207 | Oct → Dec 2009 | swine influenza | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01000207 ↗ |
| Modality | Vaccine | “cell-derived H1N1sw vaccine” NCT01000207 ↗ |
| Route | Intramuscular | “Two vaccinations were administered IM three weeks apart.” NCT01000207 ↗ |